CAPULLI, MATTIA
 Distribuzione geografica
Continente #
NA - Nord America 2.924
EU - Europa 1.689
AS - Asia 1.619
SA - Sud America 174
AF - Africa 20
OC - Oceania 2
Totale 6.428
Nazione #
US - Stati Uniti d'America 2.882
SG - Singapore 654
RU - Federazione Russa 397
CN - Cina 384
IE - Irlanda 334
TR - Turchia 196
DE - Germania 189
IT - Italia 167
SE - Svezia 154
BR - Brasile 151
VN - Vietnam 151
HK - Hong Kong 141
GB - Regno Unito 131
UA - Ucraina 117
FR - Francia 88
FI - Finlandia 56
IN - India 24
CA - Canada 19
JP - Giappone 16
MX - Messico 14
NL - Olanda 12
BE - Belgio 10
BD - Bangladesh 9
ZA - Sudafrica 8
ES - Italia 7
IQ - Iraq 7
PL - Polonia 7
AR - Argentina 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
LT - Lituania 5
PK - Pakistan 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
KR - Corea 4
MA - Marocco 4
AT - Austria 3
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
PA - Panama 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
EC - Ecuador 1
GA - Gabon 1
HR - Croazia 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 6.428
Città #
Jacksonville 446
Singapore 393
Chandler 375
Dublin 334
San Jose 254
Dallas 209
Ashburn 177
Boardman 163
Santa Clara 141
Hong Kong 138
Izmir 99
Nanjing 91
The Dalles 80
San Mateo 77
Ann Arbor 63
Lawrence 59
Princeton 59
Wilmington 57
Moscow 56
New York 55
Ho Chi Minh City 51
Beijing 46
Lauterbourg 38
L'aquila 35
Milan 35
Hanoi 31
Nanchang 29
Woodbridge 26
Bremen 25
Los Angeles 25
Seattle 22
Guangzhou 21
Kitzingen 20
L’Aquila 20
Council Bluffs 19
Shenyang 19
Tianjin 19
São Paulo 16
Tokyo 15
Phoenix 14
Dearborn 12
Dong Ket 12
Norwalk 11
Verona 11
Brooklyn 10
Brussels 10
Hebei 10
Hefei 10
Jinan 10
Mountain View 10
Chennai 9
Columbus 9
Des Moines 9
Montreal 9
Munich 9
Orem 9
San Francisco 9
Kunming 8
Chicago 7
Houston 7
Jiaxing 7
Poplar 7
Ankara 6
Johannesburg 6
Shanghai 6
Warsaw 6
Washington 6
Amsterdam 5
Aquila 5
Denver 5
Falls Church 5
Helsinki 5
Lanzhou 5
London 5
Manchester 5
Mexico City 5
Mumbai 5
Tashkent 5
Thái Nguyên 5
Boston 4
Brno 4
Changsha 4
Da Nang 4
Falkenstein 4
Frankfurt am Main 4
Fremont 4
Giugliano in Campania 4
Hải Dương 4
Ningbo 4
Piracicaba 4
Redmond 4
Rio de Janeiro 4
Shangdi 4
Strasbourg 4
Toronto 4
Turku 4
Zhengzhou 4
Baku 3
Changchun 3
Chongqing 3
Totale 4.228
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 203
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 162
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 155
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 149
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 142
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 139
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 135
Non-conventional role of haemoglobin beta in breast malignancy 134
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 129
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 126
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 126
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 125
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 124
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 122
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 122
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 121
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 120
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 120
the effect of microgravity on osteoblast metabolism 119
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 119
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 119
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 118
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 118
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 116
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 115
Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading 113
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 112
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 110
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 109
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
Multidisciplinary investigation of an ancient renal stone in a mummy from Popoli, central Italy 107
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 103
CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development 101
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 95
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 95
Regulation of breast cancer induced bone disease by cancer-specific IKKβ 92
Osteoblast and osteocyte: games without frontiers 91
Generation and culture of osteoclasts. 90
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 89
Systemic and local determinants contribute to the bone phenotype in duchenne muscular dystrophy 88
Gene microarray analysis in mouse osteoblasts reveals sets of relevant mrnas regulated under modeled microgravity 87
The Matrix PRoline/arginine-rich End Leucine-rich Repeat Protein (PRELP) Interferes with the NF-kappaB Pathway and Impairs Osteoclast Formation and Activity 85
Lipocalin 2 is a novel mechanoresponding gene involved in osteoblast differentiation and osteoblast-osteoclast cross-talk 85
Microarray Analysis of Human Bone Metastases Evidenced a Set of Genes that Segregates Patients with Metastases only in Bone from Patients with Metastases also in Visceral Organs 79
NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains 79
The molecular switch NHERF1 induces tumour phenotypic changes associated with distinct metastatic organotropism in breast cancer via its PDZ domains 78
Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis 77
Mechanisms underlying low bone density in muscular dystrophy 76
Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases 76
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis 76
Sets of genes are regulated in osteoblasts by modelled microgravity 75
EFFECTS OF 1D11 AN ANTIBODY AGAINST TRANSFORMING GROWTH FACTOR BETA (TGF-B) ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 74
Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces 74
NHERF1 programs invasive and metastatic behaviours in breast tumor cells 74
Global Transcriptome Analysis in Mouse Osteoblasts Identifies a Mechanosensing Osteoblast Gene Signature 72
Mechanisms inducing low bone density in Duchenne Muscular Dystrophy 71
Up-regulation of a set of genes in breast cancer bone metastases discloses predisposition to generate metastases also in visceral organs 71
Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss 71
A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice 70
MECHANISMS INDUCING LOW BONE DENSITY IN DUCHENNE MUSCULAR DYSTROPHY 69
A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss 69
Mechanisms Inducing Low Bone Density in Duchenne Muscular Dystrophy in Mice and Humans 64
Large-scale DNA sequencing identifies rare variants associated with Systemic Lupus Erythematosus susceptibility in known risk genes 54
Cell line-matched reference enables high-precision functional genomics 6
Totale 6.493
Categoria #
all - tutte 26.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 0 0 0 23 106 28
2021/2022325 19 30 63 22 15 4 10 16 17 8 33 88
2022/20231.029 74 55 12 125 121 111 1 62 419 6 29 14
2023/2024283 33 20 24 40 25 66 0 17 1 4 4 49
2024/20251.030 14 20 112 42 141 97 126 78 217 51 88 44
2025/20262.046 118 195 132 298 212 199 372 78 175 267 0 0
Totale 6.493